全球分类 B 型利钠肽 (BNP) 检测市场 – 行业趋势和 2030 年预测

分类 B 型利钠肽 (BNP) 检测市场分析和规模

心血管疾病 (CVD) 是全球死亡的主要原因，每年约有 1790 万人因此丧命。CVD 是一组心脏和血管疾病，包括冠心病、脑血管病、风湿性心脏病等。心脏病发作和中风占心血管疾病死亡病例的五分之四以上，其中三分之一的死亡发生在 70 岁以下的人群中。心脏病发病率的上升、诊断意识的提高以及对有效心脏病诊断测试的需求的增加是预计在 2023 年至 2030 年期间推动分诊 B 型利钠肽 (BNP) 检测市场增长的一些主要因素。

Data Bridge Market Research 分析，分类 B 型利钠肽 (BNP) 检测市场在 2022 年的规模为 50 亿美元，预计到 2030 年将达到 96 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 8.50%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

分类 B 型利钠肽 (BNP) 检测市场范围和细分      

Market Definition

B-type natriuretic peptide, also known as brain natriuretic peptide, is a 32-amino acid (AA) polypeptide produced by cardiac ventricles in response to cardiac muscle cell overstretching. Calcium ions control BNP production. BNP and ANP (atrial natriuretic peptide) function similarly and have the same biochemical activity. ANP and BNP play an important role in reducing systemic vascular resistance, which leads to a decrease in blood volume, a decrease in blood pressure, and an increase in cardiac output.

Triage B-Type Natriuretic Peptide (BNP) Testing Market Dynamics

Drivers

• Rise in awareness about diagnostics

BNP testing is one of the most important diagnostic tests used to treat cardiovascular disease. The primary purpose of BNP screening is to prevent cardiovascular diseases such as cardiac arrest and heart failure. Furthermore, a BNP spike (greater than 100 pg/ml) indicates recurrent heart disease, such as cardiac failure. This elevated value indicates a chronic medical condition known as left ventricular dysfunction. Immunoassay techniques were used to collect data. In contrast, BNP levels rise during renal failure, but testing for renal failure is not recommended due to large variations in performance. These are the certain factors that boost the growth of the market.

• Growing occurrence of cardiac diseases

The primary function of b-type natriuretic peptides is to reduce vascular system resistance in the body. This reduces the volume of blood that rushes to the heart and, as a result, lowers blood pressure. The rising prevalence of cardiac disorders is a major factor driving the B-type natriuretic peptide test market growth. This is likely to continue throughout the forecast period.

Opportunities

• Increasing demand for effectual cardiac disease diagnostic test

Growing incidence of cardiac diseases, rising awareness about diagnostics and increasing demand for effectual cardiac disease diagnostic test are some of the major factors expected to drive the growth of triage B-type natriuretic peptide (BNP) testing market in the forecast period of 2022 to 2030. Natriuretic peptides promote urine excretion, relax blood vessels, lower blood pressure, and reduce the workload on the heart. They are natural defence mechanisms designed to protect the heart from stress.

Restraints/Challenges

• Lack of awareness about health

Lack of awareness about health and welfare, as well as a lack of proper medical facilities, may pose a significant impediment to the overall growth of this market in the coming years, particularly in underdeveloped and emerging nations.

This triage b-type natriuretic peptide (BNP) testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the triage b-type natriuretic peptide (BNP) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Triage B-Type Natriuretic Peptide (BNP) Testing Market Scope

The triage b-type natriuretic peptide (BNP) testing market is segmented on the basis of application and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Acute Myocardial Infarction (AMI)
• Acute Coronary Syndrome (ACS)
• Congestive Heart Failure (CHF)
• Others

End-Use

• Laboratory Testing
• Point of Care Testing

Triage B-Type Natriuretic Peptide (BNP) Testing Market Regional Analysis/Insights

The triage b-type natriuretic peptide (BNP) testing market is analyzed and market size insights and trends are provided by country, application and end use as referenced above.

The countries covered in the triage b-type natriuretic peptide (BNP) testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the triage b-type natriuretic peptide (BNP) testing market because of the region's well-developed healthcare infrastructure and favourable reimbursement policies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing incidence of cancer such as bladder, esophagus, liver, pancreas, and others, high presence of major manufacturers across the U.S. Furthermore, technological advancements and rising foreign investment.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

分类 B 型利钠肽 (BNP) 检测市场还为您提供了详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、分类 B 型利钠肽 (BNP) 检测市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对分类 B 型利钠肽 (BNP) 检测市场的影响。数据适用于 2011-2021 年的历史时期。

竞争格局和分类 B 型利钠肽 (BNP) 检测市场份额分析

分类 B 型利钠肽 (BNP) 检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对分类 B 型利钠肽 (BNP) 检测市场的关注有关。

分类 B 型利钠肽 (BNP) 检测市场的一些主要参与者包括：

• 雅培（美国）
• Ortho-Clinical Diagnostics（美国）
• Singulex, Inc.（美国）
• Alere, Inc.（美国）
• 西门子医疗诊断公司（美国）
• 贝克曼库尔特公司（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• Randox Laboratories Ltd.（英国）
• 生物梅里埃（法国）
• Bio-Rad Laboratories Inc.（美国）

SKU-52485